ArticleMedical science monitor : international medical journal of experimental and clinical research2025
Challenges in Diagnosing and Treatment of Pediatric Necrotic Skin Conditions: A Retrospective Study.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe skin reactions with unclear pathogenesis and lack of established diagnostic and therapeutic protocols. This study investigates the triggering factors, diagnostic challenges, and therapeutic approaches in pediatric patients with necrotic skin reactions. MATERIAL AND METHODS A retrospective analysis of the medical records of 13 patients was performed. The diagnosis of necrotic skin reactions was based on medical history and clinical manifestation. Using Lund-Bowder table, the percentage of skin involvement was calculated. We analyzed demographic data, length of hospitalization, prodromal symptoms, percentage of affected skin, mucous membranes involvement, triggering factors, time form exposure to the causative agent to the onset of symptoms and treatments used. RESULTS The average length of hospitalization was 11.2±4.96 days. Prodromal symptoms were noticed in 7 patients. Lesions of mucous membranes and skin were observed in 8 children, only mucous membranes in 3, only skin in 2. A probable trigger factor was identified in 11 cases, in 2 cases the causative agent was not identified. The treatment with antibiotic and anti-inflammatory drugs resulted in improvement in 12 patients. CONCLUSIONS SJS and TEN can arise as serious complications from infections or medications in children. Prompt identification of causative agents and early intervention with tailored treatments are essential to improve outcomes and prevent lasting complications. Our findings suggest that antibiotics and anti-inflammatory drugs are effective in managing these conditions, though further research is needed to refine therapeutic strategies in the pediatric context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.